SCP
TMDX icon

Syntal Capital Partners’s Transmedics TMDX Stock Holding History

Syntal Capital Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,380
Closed -$1.32M – 126
2023
Q1 		$1.32M Buy
+17,380
New +$1.2M 0.48% 58

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return

Syntal Capital Partners's TMDX Position: Q2 2023 in Review

Syntal Capital Partners sold out of Transmedics (TMDX) in Q2 2023, closing a stake of 17,380 shares — an estimated $1.32M sold.

Syntal Capital Partners first reported a position in TMDX in Q1 2023 and held it in 1 quarter. The position peaked at $1.32M in Q1 2023. 240 funds tracked by Wall St. Rank hold TMDX as of Q2 2023.

  • Syntal Capital Partners reported no remaining Transmedics position as of Q2 2023 after selling out during the quarter.
  • Syntal Capital Partners sold 17,380 Transmedics shares in Q2 2023, an estimated $1.32M.
  • Syntal Capital Partners first reported a position in Transmedics in Q1 2023 and held it in 1 quarter.
  • Syntal Capital Partners's Transmedics position peaked at $1.32M in Q1 2023.
  • 240 funds tracked by Wall St. Rank held Transmedics as of Q2 2023.

Based on Syntal Capital Partners's 13F filing for Q2 2023, filed 7 Aug 2023.